MedPath
TGA Approval

ANTHELIOS UVMUNE 400 ULTRA INVISIBLE FLUID (495107)

495107

ANTHELIOS UVMUNE 400 ULTRA INVISIBLE FLUID

L'Oreal Australia Pty Ltd

June 30, 2025

Medicine

Medicine

Active

Listed

Active Ingredients

bemotrizinol

butyl methoxydibenzoylmethane

diethylamino hydroxybenzoyl hexyl benzoate

drometrizole trisiloxane

ecamsule

ethylhexyl triazone

methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate

octyl salicylate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ANTHELIOS UVMUNE 400 ULTRA INVISIBLE FLUID (495107) - TGA 批准文号 | MedPath